JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2008; 52:369-377, doi:10.1016/j.jacc.2008.03.059
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Google Scholar
Right arrow Articles by Stene, M. C.A.
Right arrow Articles by Tybjærg-Hansen, A.
PubMed
Right arrow Articles by Stene, M. C.A.
Right arrow Articles by Tybjærg-Hansen, A.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: GENETICS/GENOMICS

Functional Promoter Variant in Zinc Finger Protein 202 Predicts Severe Atherosclerosis and Ischemic Heart Disease

Maria C.A. Stene, MSc, PhD*, Ruth Frikke-Schmidt, MD, PhD*, Børge G. Nordestgaard, MD, DMSc{ddagger},§, Peer Grande, MD, DMSc{dagger}, Peter Schnohr, MD§ and Anne Tybjærg-Hansen, MD, DMSc*,§,*

* Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
{dagger} Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
{ddagger} Department of Clinical Biochemistry, Herlev University Hospital, Copenhagen, Denmark
§ Copenhagen City Heart Study, Bispebjerg University Hospital; all Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Manuscript received October 2, 2007; revised manuscript received February 8, 2008, accepted March 25, 2008.

* Reprint request and correspondence: Dr. Anne Tybjærg-Hansen, Chief Physician, Associate Professor, Department of Clinical Biochemistry KB3011, Section for Molecular Genetics, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. (Email: at-h{at}rh.regionh.dk).

Objectives: This study was designed to test the hypotheses that single nucleotide polymorphisms (SNPs), in zinc finger protein 202 (ZNF202), predict severe atherosclerosis and ischemic heart disease (IHD).

Background: ZNF202 is a transcriptional repressor controlling promoter elements in genes involved in vascular maintenance and lipid metabolism.

Methods: We first determined genotype association for 9 ZNF202 SNPs with severe atherosclerosis (ankle brachial index >0.7 vs. ≤0.7) in a cross-sectional study of 5,355 individuals from the Danish general population. We then determined genotype association with IHD in 10,431 individuals from the Danish general population, the CCHS (Copenhagen City Heart Study), including 1,511 incident IHD events during 28 years of follow-up. Results were verified in 2 independent case-control studies including, respectively, 942 and 1,549 cases with IHD and 8,998 controls. Finally, we determined whether g.–660A>G altered transcriptional activity of the ZNF202 promoter in vitro.

Results: Cross-sectionally, ZNF202 g.–660 GG versus AA homozygosity predicted an odds ratio for severe atherosclerosis of 2.01 (95% confidence interval [CI]: 1.34 to 3.01). Prospectively, GG versus AA homozygosity predicted a hazard ratio for IHD of 1.21 (95% CI: 1.02 to 1.43). In the 2 case-control studies, the equivalent odds ratios for IHD were 1.29 (95% CI: 1.02 to 1.62) and 1.60 (95% CI: 1.34 to 1.92), confirming the results from the prospective study. Only 2 other SNPs, which were highly correlated with g.–660A>G, also predicted risk of severe atherosclerosis and IHD. Finally, ZNF202 g.–660G versus g.–660A was associated with a 60% reduction in transcriptional activity in vitro, whereas none of the 2 correlated SNPs were predicted to be functional.

Conclusions: Homozygosity for a common functional promoter variant in ZNF202 predicts severe atherosclerosis and an increased risk of IHD.

Key Words: atherosclerosis • cardiovascular diseases • epidemiology • genetics • risk factors

Abbreviations and Acronyms
  ABI = ankle brachial index
  HDL = high-density lipoprotein
  IHD = ischemic heart disease
  MI = myocardial infarction
  SNP = single nucleotide polymorphism


Related Articles

Gaining Insights in Coronary Disease Genomics
Sarah S. Murray and Eric J. Topol
J. Am. Coll. Cardiol. 2008 52: 385-386. [Full Text] [PDF]

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A33-A34. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. S. Murray and E. J. Topol
Gaining Insights in Coronary Disease Genomics
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 385 - 386.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2008 by the American College of Cardiology Foundation.